AstraZeneca Vaccine Fails To Protect Against The South African Variant
Two doses of the AstraZeneca Covid-19 vaccine were found to have only a 10.4% efficacy against mild-to-moderate infections caused by the B.1.351 South Africa variant, according to a phase 1b-2 clinical trial published on Tuesday in the New England Journal of Medicine. This is a …
COVID-19 Survivors at Risk of Depression and Other Disorders
Two studies have given insight into how COVID-19 symptoms are associated with the probability of subsequent depressive symptoms or psychiatric disorders. The first study by researchers at Massachusetts General Hospital in Boston has found that some COVID-19 patients who suffer from prolonged symptoms after …
Novavax Covid-19 Vaccine Performs Well In Clinical Trials, But Variants Remain A Threat
More than 330 million vaccinations have been administered in the fight against Covid-19, and a new vaccine candidate is now ready to enter the ring. Novavax recently completed its final analyses and will seek FDA and international approval in the coming weeks. …
Molnupiravir: A New Hope For Prevention And Treatment Of Covid-19 And Other Dangerous Viruses
A new Covid-19 therapy has completed its phase two human trial and the results are promising. Molnupiravir, developed by Ridgeback Biotherapeutics LP and Merck & Co., reached its endpoint objective of reducing the length of Covid-19 infections, according to a Merck press …
New Study Using Live Virus Explores Whether Pfizer-BioNTech Vaccine Protects Against Variants
When new variants of SARS-CoV-2, the virus that causes Covid-19, were discovered to be circulating around the world, the first question for many was whether they would present a serious problem for nascent vaccination programs against Covid-19. While the answer still eludes …
The Covid Syndemic: The Mental Health Crisis Of Mental Health Workers
A syndemic refers to multiple interrelated epidemics happening at the same time. Covid-19 has unleashed and amplified a number of simultaneous personal, social, medical, political, and economic crises. This is the first in a series of articles exploring the impact of the …
Lessons From The Past And Present For Controlling Covid-19: Polio
This article is the first in an ongoing series about what we can learn from successful efforts to vaccinate against other diseases and apply to interventions against Covid-19. Though we’ve cycled through many kinds of public health interventions in our struggle to …
How COVID-19 could make us healthier
COVID-19 has exposed countless weaknesses and inequities in our health care systems, with long-term effects that will be felt for generations to come. Yet it has also given us an important opportunity to improve where we have failed. Public health is now …
Schools Must Reconsider Accelerating Plans To Reopen In Light Of Dangerous New Covid-19 Variants
Nearly a year has passed since schools across the country began shuttering their doors to protect students, educators, and their families from Covid-19. Since then, many parents juggling work and schooling duties have incurred more stress while making less money; a high percentage of kids …
Should Anticoagulants Be Used Early Or Late In Patients Hospitalized With Covid-19: Two Conflicting Answers
Doctors treating patients with a new disease face uncertainties. Will the treatment benefit or harm the patient or make no measurable difference. The results of controlled clinical trials and the difference between treatment and placebo, provide the guideposts for decisions. What must …
Recent Comments